BrainHQ
BrainHQ is an intervention with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms
RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms
Brain Stimulation and Cognitive Training - Efficacy
Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI
Application of LLM Care and Related Affective Computing Systems on People With Parkinson's Disease
Clinical Trials (8)
RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms
RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms
Brain Stimulation and Cognitive Training - Efficacy
Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI
Application of LLM Care and Related Affective Computing Systems on People With Parkinson's Disease
Intervention Comparative Effectiveness for Adult Cognitive Training
Brain Stimulation and Cognitive Training
Cognitive Reserve and Second Language Acquisition
All 8 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 8